Table 4.
Seal-wing PEB | Iopromide-coated PEB | EES | Seal-wing vs. iopromide- PEB | Seal-wing PEB vs. EES | ||
---|---|---|---|---|---|---|
Diabetes mellitus | pa | |||||
Patients/lesions, n | 18/19 | 16/16 | 15/16 | 0.024 | 0.450 | |
Late lumen loss, mm | Mean | 0.64 | 0.12 | 0.48 | ||
SD | 0.63 | 0.33 | 0.86 | |||
Median | 0.33 | 0.06 | 0.12 | |||
ISR length >10 mm | ||||||
Patients/lesions, n | 36/41 | 42/44 | 44/47 | 0.0006 | 1.000 | |
Late lumen loss, mm | Mean | 0.53 | 0.16 | 0.53 | ||
SD | 0.57 | 0.50 | 0.67 | |||
Median | 0.37 | 0.05 | 0.26 | |||
Vessel diameter < 3 mm | ||||||
Patients/lesions, n | 49/53 | 49/54 | 47/52 | <0.0001 | 0.564 | |
Late lumen loss, mm | Mean | 0.53 | 0.12 | 0.42 | ||
SD | 0.60 | 0.48 | 0.63 | |||
Median | 0.37 | 0.05 | 0.16 |
aMann–Whitney U test